KE
KERX
Keryx Biopharmaceuticals, Inc
3.36
+0.00%
2018-12-21 · 2869d old
52-week range
2.47
5.98
1-month+30.7%
3-month+6.7%
1-year-26.0%
3-year-37.5%
5-year-73.0%
vs 50-day+9.9%
vs 200-day-14.2%
Volatility57%
Beta1.12
$ vol/day$4M
ATH19.86
From ATH-83.1%
Nothing written about KERX yet.
Be the first — call it long or short with an entry we price for you,
or post a neutral write-up that takes no side.
Create a free account
2026AprJulOct
bought sold · bigger dot, bigger trade · follows the chart’s range
2 members · 3 buys / 1 sells · $5K–$75K disclosed · latest filing Aug 4, 2017 · full tracker ›
| When | Member | Size | Amount | Price then | |
|---|---|---|---|---|---|
| 9.7y | buy | $1K–$15K | 5.45 | ||
| 9.9y | buy | $1K–$15K | 5.74 | ||
| 10.5y | buy | $1K–$15K | 5.08 | ||
| 11.4y | sell | $1K–$15K | 10.40 |
Model view — historical tendencies for the days ahead, not a forecast
Next 1 day
-0.5%
Next 1 week
+1.2%
Next 1 month
+2.9%
Seasonality
Mildly positive window
Next 30 days (to Nov 28): +4.2% median,
56% of the last 18 years finished up.
20-year seasonality chart →
Mean reversion
Neutral — RSI(2) at 60
RSI(2) under 15 is oversold (this name has historically bounced); over 85 is overbought.
Its dip-buy edge in history is -0.06%/day.
Mean-reversion stats →
1-month breakdown —
Market · β 1.12 +2.9% · Seasonal tilt -0.0%
$4M/day volume
57% volatility
-26% 1-year
-83% from ATH
52-week range · 25% of the way up · -44% from the high
$2.47$5.98
Not investment advice.
Continue with Google